|
Introduction
T he European Influenza Surveillance Scheme
(EISS) aims to facilitate collaboration between European countries on
influenza surveillance (see article p. 147-57). EISS has developed two
protocols to evaluate the quality of clinical and virological data collected
by surveillance networks based on sentinel practitionners (sp) reporting
in Europe. The rationale for developing these protocols was to: a) move
towards standardisation of data collection, b) improve the surveillance
of influenza activity and data quality, c) facilitate the sharing of
data at a European level, and d) encourage and facilitate access to
new member states wanting to join the Scheme (1,2). This paper briefly
describes the protocol to evaluate the quality of clinical data collected
by SPs and the resulting experiences during the 2001–02 influenza season.
Methods
The EISS evaluation protocol is based on
the Centers for Disease Control and Prevention (CDC Atlanta), and the
World Health Organization (WHO) guidelines (2,3). We designed and pre-tested
in the Netherlands and France two questionnaires to be administered:
(a) face to face to the networks’ coordinators at regional and/or national
level, and (b) either face to face or by telephone, depending on logistic
constraints, to a representative sample of sentinel practitioners -in
terms of either or both geographical location, and medical speciality
(general practitioners/paediatricians).
The questionnaires addressed the following
networks’ attributes, at the coordination and / or the sentinel practitioners’
levels:
• Sensitivity and specificity of the network,
including information on the number of SPs and the use of : 1) a case
definition for influenza and the adherence of SPs to it, 2) an epidemic
threshold to estimate the magnitude of morbidity related to influenza,
3) incidence of ‘influenza-like illness’ (ILI) or ‘acute respiratory
infection’ (ARI) as a numerator for measuring influenza activity, 4)
a population-based or encounters-based denominator, 5) age groups for
the classification of cases, and 6) criteria for collection of clinical
specimens;
• Representativeness of sentinel practitioners
to all national/regional practices, and of the population covered by
sentinel practitioners to the general population;
• Timeliness for reporting weekly data, and
ability to detect changes in trends in a timely way;
• Network output including reports, publications,
communication, training to sentinel practitioners or staff, and activities
leading to improved practice;
• Resources for the network.
We implemented the evaluation protocol during
on site visits, at both coordination and sentinel practitioners levels,
in the Belgian and three regional Spanish networks (Aragón, Castilla
y León, and the Madrid Community). These networks were selected
according to their EISS membership, the willingness of their coordinators
to participate in the evaluation, logistic constraints, and because
the EISS coordination centre wanted to evaluate a national network made
up of regional networks (in Spain). The standardised evaluation protocol
includes a report format to facilitate the formulation of conclusions
and recommendations based on generally accepted surveillance practices,
obtained from a literature review, WHO/CDC standards, current consensus
reached within EISS, and surveillance practices in Europe (4).
Results
All networks fulfilled either international
standards or EISS requirements in terms of : 1) simplicity and acceptability
of influenza surveillance activities, 2) types of numerator (ILI in
all networks as well as ARI in Belgium), age groups, denominators (population-based),
case definitions and criteria for swabbing, 3) completeness of reports
(over 95%), 4) use of epidemic thresholds (not used in Aragón),
5) laboratory support, 6) timeliness of reporting data and detecting
trends, and 7) resources (see table).
Table. Preliminary results of the evaluation
protocol
Caractéristiques
/
Characteristics |
Belgique /
Belgium |
Espagne / Spain
|
| |
|
Aragón
|
Castilla
y León
|
Madrid
|
|
Evaluation sur site (jours)
On-site evaluation (days)
|
7
|
5
|
5
|
5
|
|
Population totale (million)*
Total population (million)*
|
10.1
|
1.2
|
2.5
|
5.4
|
|
Nombre de médecins sentinelles interviewés Number
of sentinel practitioners interviewed
|
18 (35%)
|
10 (14%)
|
10 (29%)
|
9 (36%)
|
|
Nombre de médecins sentinelles et % de tous les médecins
généralistes nationaux/régionaux /
Number of SPs and % of all national/regional GPs
|
51 (0.4%)
|
70 (7.0%)
|
35 (1.4%)
|
25 (3.4%)
|
|
Représentativité de la population couverte par
le réseau
Representativeness of population covered by network
|
Géographique
(province)
Geographical (province) |
Age, facteurs socio-économiques Age, socio-economical
factors
|
Age, urbain/rural/ facteurs socio-économiques
Age, urban/rural, socio-economical factors
|
Age, sexe, urbain / rural
Age, sex, urban/rural
|
|
Pourcentage des médecins sentinelle interviewés
utilisant la définition de cas standardisée du réseau
Percentage of interviewed SPs using the network standardised
case definition
|
44%
|
30%
|
40%
|
11%
|
|
Nombre de prélèvements reçus par le laboratoire
(saison 2001-2002)
Number of swabs received at the laboratory (2001-2002 season)
|
1 200
|
165
|
100
|
142
|
|
Délai moyen pour la déclaration des résultats
des prélèvements aux médecins sentinelle
(jours)
Average delay for reporting swab results to SPs (days)
|
2
|
11
|
18
|
21
|
*Estimée en janvier 2001 / Estimated
in January 2001.
Le protocole d’évaluation
a été mis en place par les réseaux de surveillance
de la grippe en Belgique, et en Espagne (Castilla y León, Aragón
et Madrid). Saison de la grippe 2001 – 2002 / The evaluation protocol
was implemented in influenza surveillance networks in Belgium, and Spain
(Castilla y León, Aragón and Madrid). Influenza season
2001–02.
Each network coordinator has received an
evaluation report that is based on a standard format and includes a
description of the network’s attributes, conclusions and recommendations.
For all networks, the recommendations made to the coordinators included
improving sentinel practitioners’ adherence to the national/regional
case definitions and criteria for swabbing. Additionally, the following
network-specific recommendations were made:
• In Belgium, to increase the number of sentinel
practitioners, to improve their geographical representativeness, to
organise regular meetings to discuss epidemiological and virological
issues of the previous season, and to harmonise the methods used to
establish the epidemic thresholds for ARI and ILI;
• In Spain, to increase the number of regional
networks collecting and reporting clinical and virological data to the
national level (currently eight out of 17 Spanish regions), and to improve
the standardisation of methods used to establish epidemic thresholds
in regional networks. At a regional level, to reduce the delay of reporting
swab results to sentinel practitioners.
Conclusion
The EISS group has developed an evaluation
protocol to assess the quality of clinical data collected by sentinel
practitioners within EISS. This protocol allows an in-depth description
of the surveillance network, and the sharing of national/regional experiences
with other networks in Europe and elsewhere. It should facilitate the
improvement and harmonisation of influenza surveillance activities in
Europe, and be a valuable reference for new networks wanting to join
EISS.
Acknowledgements
The Health and Consumer Protection Directorate-General
of the European Commission funded this evaluation project. We would
like to thank the following persons for testing and implementing the
evaluation protocol:
Aad Bartelds (Netherlands Institute for Health
Services Research, NIVEL, Utrecht): Anne Mosnier (France GROG, Paris);
Fernande Yane and Frederic Pierquin (Institut Scientifique de Santé
Publique, Brussels); Tomas Vega and Raul Ortiz de Lejarazu (Consejería
de Sanidad y Bienestar Social y Centro de Gripe de Valladolid, Castilla
y León); Maria Ordobas and Silvia Fernandes (Consejería
de Sanidad, Comunidad de Madrid), Alberto Larrosa and Marta Fajó
(Servicio Aragonés de Salud, Zaragoza); Manuel Omeñaca
Teres (Laboratorio de Microbiología, Hospital Universitario Miguel
Servet, Zaragoza); Pilar Perez (Laboratorio de Referencia de Virología,
Centro Nacional de Microbiología, Instituto Carlos III); Salvador
de Mateo Ontañón (Servicio de Vigilancia Epidemiológica,
Centro Nacional de Epidemiología, Madrid); and all sentinel practitioners
who participated in the evaluation in Aragón, Belgium, Castilla
y León, France, Madrid Community, and the Netherlands.
A copy of the evaluation protocol can be
obtained by contacting Jean-Francois Aguilera (jaguilera@phls.org.uk).
It will be posted on the EISS website (www.eiss.org) by the end of 2002.
|